The Top 4 Best Analyst Coverage On Teva Pharmaceutical Industries
Teva Pharmaceutical Industries Ltd. (TEVA) is slated to announce second quarter 2015 earnings results on Thursday, July 30, before market open. The company released preliminary Q2 results on July 27, estimating $4.97 billion in revenue and non-GAAP earnings of $1.43 per share. The preliminary earnings raised the company’s full-year 2015 EPS guidance to be in…